574 related articles for article (PubMed ID: 16699568)
1. Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice.
Mallaley PP; Halperin SA; Morris A; MacMillan A; Lee SF
Can J Microbiol; 2006 May; 52(5):436-44. PubMed ID: 16699568
[TBL] [Abstract][Full Text] [Related]
2. Induction of humoral immunity in response to immunization with recombinant Mycobacterium bovis BCG expressing the S1 subunit of Bordetella pertussis toxin.
Medeiros MA; Armôa GR; Dellagostin OA; McIntosh D
Can J Microbiol; 2005 Dec; 51(12):1015-20. PubMed ID: 16462859
[TBL] [Abstract][Full Text] [Related]
3. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
Huang Y; Hajishengallis G; Michalek SM
Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570
[TBL] [Abstract][Full Text] [Related]
4. Development of safer pertussis DNA vaccine expressing non-toxic C180 polypeptide of pertussis toxin S1 subunit.
Kamachi K; Arakawa Y
Vaccine; 2007 Jan; 25(6):1000-6. PubMed ID: 17050047
[TBL] [Abstract][Full Text] [Related]
5. Synergistic BM-DC activation and immune induction by the oral vaccine vector Streptococcus gordonii and exogenous tumor necrosis factor.
Mayer ML; Phillips CM; Stadnyk AW; Halperin SA; Lee SF
Mol Immunol; 2009 May; 46(8-9):1883-91. PubMed ID: 19278729
[TBL] [Abstract][Full Text] [Related]
6. Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein.
Lee SF; Halperin SA; Salloum DF; MacMillan A; Morris A
Infect Immun; 2003 Apr; 71(4):2272-5. PubMed ID: 12654855
[TBL] [Abstract][Full Text] [Related]
7. Expression of diphtheria toxin in Streptococcus mutans and induction of toxin-neutralizing antisera.
Lee CW; Halperin SA; Morris A; Lee SF
Can J Microbiol; 2005 Oct; 51(10):841-6. PubMed ID: 16333343
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of Salmonella vector vaccines expressing SBR of Streptococcus mutans under the control of a T7-nirB (dual) promoter system.
Salam MA; Katz J; Zhang P; Hajishengallis G; Michalek SM
Vaccine; 2006 Jun; 24(23):5003-15. PubMed ID: 16621196
[TBL] [Abstract][Full Text] [Related]
9. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
Tobias J; Lebens M; Bölin I; Wiklund G; Svennerholm AM
Vaccine; 2008 Feb; 26(6):743-52. PubMed ID: 18191006
[TBL] [Abstract][Full Text] [Related]
10. [Protective efficacy of a new fusion anti-caries DNA vaccine encoding antigens of both Streptococcus mutans and Streptococcus sobrinus].
Sun JH; Niu YM; Fan MW; Xu QA; Yang XC
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(32):2286-91. PubMed ID: 20095345
[TBL] [Abstract][Full Text] [Related]
11. Induction of immune responses to functional determinants of a cell surface streptococcal antigen.
Todryk SM; Kelly CG; Munro GH; Lehner T
Immunology; 1996 Jan; 87(1):55-63. PubMed ID: 8666436
[TBL] [Abstract][Full Text] [Related]
12. Surface expression of a protective recombinant pertussis toxin S1 subunit fragment in Streptococcus gordonii.
Lee SF; March RJ; Halperin SA; Faulkner G; Gao L
Infect Immun; 1999 Mar; 67(3):1511-6. PubMed ID: 10024603
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant.
Saito M; Otake S; Ohmura M; Hirasawa M; Takada K; Mega J; Takahashi I; Kiyono H; McGhee JR; Takeda Y; Yamamoto M
J Infect Dis; 2001 Mar; 183(5):823-6. PubMed ID: 11181162
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations.
Gracia A; Polewicz M; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
Vaccine; 2011 Feb; 29(8):1595-604. PubMed ID: 21215343
[TBL] [Abstract][Full Text] [Related]
15. Oral colonization and immune responses to Streptococcus gordonii expressing a pertussis toxin S1 fragment in mice.
Lee SF; Halperin SA; Wang H; MacArthur A
FEMS Microbiol Lett; 2002 Mar; 208(2):175-8. PubMed ID: 11959433
[TBL] [Abstract][Full Text] [Related]
16. Construction of an unmarked recombinant BCG expressing a pertussis antigen by auxotrophic complementation: protection against Bordetella pertussis challenge in neonates.
Nascimento IP; Dias WO; Quintilio W; Hsu T; Jacobs WR; Leite LC
Vaccine; 2009 Dec; 27(52):7346-51. PubMed ID: 19782111
[TBL] [Abstract][Full Text] [Related]
17. Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA.
Shin SJ; Bae JL; Cho YW; Lee DY; Kim DH; Yang MS; Jang YS; Yoo HS
FEMS Immunol Med Microbiol; 2005 Feb; 43(2):155-64. PubMed ID: 15681145
[TBL] [Abstract][Full Text] [Related]
18. Mucosal and systemic immunization with targeted fusion anti-caries DNA plasmid in young rats.
Liu GX; Xu QA; Jin J; Li YH; Jia R; Guo JH; Fan MW
Vaccine; 2009 May; 27(22):2940-7. PubMed ID: 19428904
[TBL] [Abstract][Full Text] [Related]
19. Specific lung mucosal and systemic immune responses after oral immunization of mice with Salmonella typhimurium aroA, Salmonella typhi Ty21a, and invasive Escherichia coli expressing recombinant pertussis toxin S1 subunit.
Walker MJ; Rohde M; Timmis KN; Guzmán CA
Infect Immun; 1992 Oct; 60(10):4260-8. PubMed ID: 1398937
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccine encoding pertussis toxin S1 subunit induces protection against Bordetella pertussis in mice.
Kamachi K; Konda T; Arakawa Y
Vaccine; 2003 Nov; 21(31):4609-15. PubMed ID: 14575775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
